UNSPSC 41141919: Angiotensin converting enzyme (a.c.e.) test system

In this classification, Angiotensin converting enzyme (a.c.e.) test system connotes a device used to measure Angiotensin converting enzyme (a.c.e.) levels. US FDA regulates Angiotensin converting enzyme (a.c.e.) test system under 21 CFR 862.1090 and under FDA product code KQN.

UNSPSC 41141919 Angiotensin converting enzyme (a.c.e.) test system is a Commodity code that state and local governments use to procure laboratory testing kits and reagents for forensic, toxicology, and public health analysis. Recent solicitations under this code show state agencies and county governments buying Direct ELISA testing kits for substance screening, certified drug reference standards for forensic validation and analysis, and DNA screening kits for laboratory operations. The Texas Department of Public Safety, Pinellas County in Florida (in partnership with the Florida Department of Law Enforcement), and the Texas Health and Human Services Commission have posted opportunities within the past four months, indicating steady demand from state laboratory operations and forensic divisions. The scope spans immunological reagent kits targeting specific drug metabolites and analytes, certified reference materials meeting ISO/IEC 17025 accreditation standards with specified purity levels, and molecular biology kits for DNA fragment evaluation. Issuing bodies include state forensic laboratories, public health agencies, and criminal justice departments; county forensic labs serving regional populations; and state health and human services commissions sourcing on behalf of public laboratory systems.

Geographic concentration shows Texas and Florida as the primary recent markets. The Texas Department of Public Safety Crime Lab Division posted an IFB for immunalysis reagent kits due July 23, 2026, comprising 12 line items of Direct ELISA testing kits for cannabinoids, opiates, PCP, amphetamines, barbiturates, and other controlled substances with estimated unit quantities of 3 to 30 per item. The Pinellas County Forensic Laboratory, in partnership with the Florida Department of Law Enforcement and supported by Paul Coverdell federal forensic science funding, issued an Invitation to Quote on April 23, 2026, for 131 line items of certified drug standards with ISO/IEC 17025 and ISO 17034 accreditation required, pricing held firm for 12 months, and Pinellas County Certified Small Business Enterprise preference available. The Texas Health and Human Services Commission posted an IFB due January 29, 2026, for QIAxcel and QIAamp DNA screening kits for the DSHS state laboratory, with historical spend between $25,050.00 and $30,000.00 in Fiscal Year 2025 and initial contract term through August 31, 2026 with one-year extension option. These jurisdictions typically require vendor compliance with HUB subcontracting plans, submission of financial documentation and performance history, and delivery to specific laboratory loading docks within 30 to 60 days of award.